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Abstract 
Osteocalcin, also known as bone γ-carboxyglutamic acid, is an osteoblast-specific 
protein that has long be utilized in research as a marker of bone formation.  Recently, 
osteocalcin has been recognized as a major regulator of glucose metabolism and insulin 
sensitivity.  Osteocalcin deficient mice were shown to have decreased insulin secretion 
and insulin sensitivity and injections of recombinant osteocalcin reversed these 
dysfunctions.  Furthermore, osteocalcin has been associated with obesity and insulin 
resistance in human adults.  Osteocalcin has also been shown to transiently decrease 
following ingestion of a glucose load, while acute and long-term exercise has been 
shown to elevate osteocalcin in adults.  Few studies investigating the temporal effects of 
glucose and/or exercise on osteocalcin levels have been published.  Determining how 
OC responds to exercise and nutrients may help the understanding of how exercise 
influences glucose metabolism and lead to OC becoming a potential therapeutic target 
for type 2 diabetes. Therefore the purpose of this study is to examine the effects of a 
glucose load with or without a prior exercise bout on serum osteocalcin in overweight 
young men.  Fifteen overweight young men were recruited.  Subjects reported to the lab 
on three separate occasions.  On two separate trials, conducted on in randomized order 
and separated by at least 4 days, serum carboxylated osteocalcin, undercarboxylated 
osteocalcin, glucose and insulin were measured during a standard 75-gram, 2-hour oral 
glucose tolerance test (OGTT).  During one visit the subjects rested prior the glucose 
drink, while on the other visit aerobic interval exercise (EX) was performed just prior to 
ingestion of the glucose.  There were no significant differences between the OGTT and 
EX trials in baseline serum cOC (32.24±21.32 vs 26.86±15.68 ng/mL, respectively), 
x 
serum uOC (8.48±3.23 vs 9.03±3.68 ng/mL, respectively) or serum tOC (40.72±20.88 
vs 35.90±17.98 ng/mL, respectively).   There were also no significant differences 
between the OGTT and EX trials for cOC AUC (3466±2238 vs.3345±1873 ng min/mL, 
respectively; p=0.470), uOC AUC (932±385 vs. 989±422 ng min/mL, respectively; 
p=0.295), or tOC AUC (4399±2319 vs. 4334±2018 ng min/mL, respectively; p=0.727).  
Additionally, exercise did not alter the blood glucose or insulin concentrations 
compared to the resting trial.  There were no significant associations between 
measurements of cOC, uOC or tOC and glucose or insulin at baseline or the post-
glucose AUC.  This study is the first to report the temporal response of serum OC 
within 2 hours of glucose ingestion.  The results of the study reveal that a neither a 
bolus dose of glucose, nor exercise preceding the glucose drink altered serum cOC, 
uOC or tOC in sedentary, overweight young men.  Additionally, there was no 
relationship between postprandial changes in serum cOC, uOC or tOC with glucose or 
insulin with or without a prior exercise bout.  Therefore, OC does not appear to play a 
role in glycemic control in overweight but otherwise healthy young men.
1 
Chapter I: Introduction 
 
The Economic Costs of Diabetes report of 2007 states that for every five U.S. 
dollars spent on health care, one dollar is spent caring for someone with diagnosed 
diabetes and one out of every ten is spent on health care costs attributed to diabetes [1].  
Since the early 1960s, the prevalence of adult obesity in the United States increased 
from 13.4 to 35.7% and in 2008 over two thirds (68%) of US adults were considered 
overweight (body mass index, BMI > 25) [2].  In 2009-2010, ~17% of children and 
adolescents in the United States were considered obese [3].  Since type 2 diabetes 
(T2D) is often preceded by development of obesity, both of which have increased 
prevalence, an urgent public health need exists to develop novel strategies to prevent 
and/or treat obese populations at high risk of developing diabetes.  This is especially 
important in the younger population where obesity can track into adulthood [4]. 
While skeletal muscle has long been known to regulate energy metabolism, 
adipose tissue and bone have recently become appreciated for their roles in regulating 
inter-organ nutrient metabolism.  The interaction of bone-specific proteins and glucose 
metabolism was recently demonstrated in studies of a mouse model harboring an 
osteoblast-specific protein knockout that contained a side-effect of abnormally large 
visceral fat pads [5].  The protein of interest in that study was osteocalcin (OC), also 
known as bone γ-carboxyglutamic acid (Gla) protein (BGP), is an osteoblast-specific 
protein found in circulation and is one of the ten most abundant proteins found within 
the human body so elucidation of its effects, especially beyond the bone, is essential to 
the understanding of human physiology [6].  Since OC was long thought to represent 
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osteoblast-specific activity, this abundant protein has frequently been measured as a 
marker of bone formation [7].  However, with the recent work by Ducy and Karsenty 
[8], the metabolic regulatory properties of OC have become increasingly apparent.  For 
example, OC knockout mice have elevated blood glucose and lower serum insulin 
levels and also develop insulin resistance and have decreased β-cell proliferation [8].  
OC is produced by the osteoblasts and undergoes post-translational modification in a 
vitamin-K dependent process so that there are two distinct forms found within the body, 
carboxylated (cOC) and undercarboxylated (uOC) [9].  While both isoforms are found 
in circulation and have been associated with glucose metabolism in human cross-
sectional research, animal models show that uOC is the isoform actively involved in 
insulin secretion and sensitivity [8]. 
Recently it has been reported that obese people and/or those with T2D, both of 
which are likely to demonstrate glucose intolerance and insulin resistance, have 
decreased serum OC [10-13].  While it is established that both acute and chronic 
exercise results in increased insulin sensitivity and postprandial glucose disposal, the 
exact mechanism by which this occurs is not yet clear [14].  It has been proposed that a 
circulating protein (or proteins) is required for the post-exercise enhancement of insulin 
sensitivity [15].  Since OC is one of the most abundant proteins found in the circulation, 
is decreased in those with dysfunctional glucose metabolism, and exercise has the 
ability to directly affect the tissue from which OC is released (bone, due to loading 
stimulation), it is reasonable to propose that OC may be a serum factor that mediates 
improved insulin sensitivity following exercise. 
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While longitudinal studies have shown that serum OC can be influenced by 
weight fluctuations, exercise, and nutrition in adults, there has not been sufficient 
research conducted to determine the acute effects of nutrition and/or exercise on 
circulating OC.  Since the prevalence obesity and T2D has risen there is need for 
successful intervention strategies and reliable serum markers to prevent and treat insulin 
resistance.  OC may be a potential mediator of insulin action that could serve as a 
marker of diabetes risk or a potential target for treatment.  However, initial studies to 
characterize how OC and uOC vary with acute nutrient intake and exercise have not 
been performed.  Therefore, the purpose of this study was to examine the changes in 
serum OC of overweight young men in an acute (2 hours) time period following 
ingestion of glucose and the influence of exercise preceding glucose ingestion. 
 
Research Questions 
1. Do circulating cOC, uOC, or total OC concentrations decrease from baseline 
(fasting) levels in an acute time period (<2 hours) following ingestion of a glucose load 
in overweight young men? 
2. Can an acute bout of aerobic interval exercise prior to ingestion of a glucose 
load blunt the decline in postprandial circulating cOC, uOC, or total OC? 
3. Are the changes in insulin and/or glucose following ingestion of a glucose load 
related to the fasting concentrations and/or postprandial changes in cOC, uOC, or total 
OC? 
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4. Does an acute bout of aerobic interval exercise influence the relationship 
between postprandial changes in serum insulin and/or glucose and postprandial changes 
in serum cOC, uOC, or total OC? 
5. Do the components of body composition (i.e. fat mass, lean mass, bone mineral 
density) correlate with baseline values or postprandial changes in cOC, uOC, or total 
OC? 
 
Hypotheses 
1. It is hypothesized that circulating cOC, uOC, and total OC concentrations will 
decrease following glucose ingestion in overweight young men. 
2. It is hypothesized that an acute bout of aerobic interval exercise will attenuate 
the postprandial decline in cOC, uOC, and total OC. 
3. It is hypothesized that postprandial changes in insulin and/or glucose will 
associated with baseline concentrations and/or postprandial changes in cOC, uOC, and 
total OC. 
4. It is hypothesized that an acute bout of aerobic interval exercise will alter the 
relationship between postprandial changes in serum insulin and/or glucose and 
postprandial changes in serum cOC, uOC, and total OC. 
5. It is hypothesized that body composition measures, specifically fat mass and 
bone mineral density, will be significantly associated with baseline values and 
postprandial changes in cOC, uOC, and total OC. 
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Limitations 
1. The study population was limited to overweight to obese class I but otherwise 
healthy, young adult males.  This inclusion criteria means that the results can 
only be applied to this narrow population.  It is unknown if the menstrual cycle, 
age or metabolic disease would result in alterations to osteocalcin in response to 
glucose with or without exercise. 
2. Osteocalcin was the only bone turnover protein measured therefore the subjects’ 
bone remodeling phase was not fully characterized.  The measurement of 
additional bone turnover markers would indicate if the exercise protocol was 
able to induce bone formation.  Additionally, undercarboxylated osteocalcin is 
released in an absorption-dependent manner and thus measurement of bone 
resorption would have been useful to determine the effect of bone formation and 
resorption on the isoforms of osteocalcin. 
3. Hemoglobin and hematocrit were not measured during the exercise visit 
therefore it is unknown if plasma volume changes occurred.  Exercise often 
results in a shift of water out of the vascular space, resulting in 
hemoconcentration of some of the circulating proteins independent of a 
treatment effect of exercise per se.  Although this type of concentration shift is 
generally small for the type of short-term exercise in moderate temperature and 
humidity performed in the current study, applying the volume correction 
described by Dill and Costill [16] would have been useful to confirm the 
magnitude of effect. 
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Assumptions 
1. Subjects were honest in answering all questions on health status and exercise 
readiness questionnaires.  The inclusion criteria for this study stated that subjects 
must be overweight to class I obese but otherwise apparently healthy.  
Withholding of any information about personal or family health history or 
exercise readiness could have placed the subject at increased risk for 
cardiovascular complications during the exercise bout.  Additionally, osteocalcin 
has been shown to be decreased diabetes and it is speculated that persons with 
lower levels of osteocalcin could have a greater response to exercise so it was 
important for subjects to be free of diabetes.  Fasting glucose samples revealed 
that no subjects fit the criteria for diabetes so the results were not altered by this 
factor. 
2. Subjects adhered to the same diet and exercise regimen in the three days prior to 
each trial visit.  Osteocalcin is carboxylated in a vitamin K-dependent manner 
and therefore a change in diet would affect the carboxylation status of 
osteocalcin.  However, given the short timeframe that this study was completed, 
it is unlikely that any additional dietary vitamin K would have impacted the 
results.  Additionally, exercise can stimulate bone formation and alter glucose 
metabolism in the following days.  An increase in exercise regimen in the days 
preceding a study visit could result in increased osteocalcin and/or improved 
glucose tolerance during the study visits.  
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Abbreviations 
OC – Total osteocalcin 
cOC –Carboxylated osteocalcin 
uOC – Undercarboxylated osteocalcin 
BGP – Bone γ-carboxyglutamic acid protein  
BMI – Body mass index 
HA – Hydroxyapatite 
Esp – Embryonic stem cell protein tyrosine phosphatase 
OST-PTP – Osteotesticular protein tyrosine phosphatase 
GTT – Glucose tolerance test 
OGTT – Oral glucose tolerance test 
InsR – Insulin receptor 
HOMA-IR – Homeostatic model assessment-insulin resistance 
T2D – type 2 diabetes 
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Chapter II: Review of Literature 
 
Synthesis and Release of Osteocalcin 
Osteocalcin (OC) is expressed almost exclusively by osteoblasts; however, OC 
mRNA has been measured in the ovaries, testes, prostate, skeletal muscle, thyroid and 
adipose tissue [17, 18].  Initially, OC is formed as a 95-99 residue pre-pro-OC and 
subsequent cleavage of the 23-residue prepeptide results in pro-OC [19].  Pro-OC then 
undergoes further modification through vitamin K-dependent γ-carboxylation at 
residues 17, 21, and 24 [20].  Fully carboxylated OC (cOC) has a high binding affinity 
to hydroxyapatite (HA) and calcium [20-22].  While this binding affinity of cOC 
suggests that it would be fully incorporated into the bone matrix, its presence in serum 
concentration demonstrates that some cOC is released into circulation.  Approximately 
one third of newly synthesized total OC is released into circulation [23] but the 
concentration varies with sex, age, body weight, and height [24].  While most 
circulating OC is in the cOC form, there is also circulating OC that is not completely 
carboxylated (undercarboxylated, uOC).  Originally, uOC was thought to be a result of 
vitamin K deficiency [25] or use of the medication, warfarin, or other anticoagulants 
[26].  Serum OC concentration fluctuates with a circadian rhythm in adult humans [27], 
with highest levels during nocturnal hours, and trough levels occurring around noon-
time.  Likewise, a study conducted on seven children (Tanner stage I-III) reported that 
children display a diurnal variation in serum OC with peak levels occurring in the 
morning hours and troughs in the early afternoon hours [28]. 
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Discovery of Osteocalcin as a Metabolic Factor 
While conducting research on bone physiology, the research team led by Gerard 
Karsenty generated an Osteocalcin-/- (Ocn-/-) mouse model to determine the effect on 
bone formation [5].  The results revealed that OC had an influence on bone formation, 
but Karsenty and colleague Patricia Ducy also noticed that these mice had an 
abnormally high amount of visceral adipose tissue [8].  This keen observation provided 
the first evidence that the skeleton may play a role in whole-body energy metabolism.  
Since osteoblasts have a scarcity of cell-specific genes, Karsenty and colleagues began 
a search for an osteoblast-specific gene that could regulate energy metabolism.  They 
created mutant mice with the embryonic stem cell protein tyrosine phosphatase (Esp) 
gene inactivated [8].  The Esp gene (also termed Ptprv) encodes for a receptor-like 
protein tyrosine phosphatase termed osteotesticular protein tyrosine phosphatase (OST-
PTP) [29].  The Esp-/- pups had a severe reduction in blood glucose levels prior to milk 
ingestion that was maintained through adulthood, even following random feedings [8].  
The reduction in blood glucose was explained by an increase in serum insulin in both 
newborn and adult Esp-/- mice.  Insulin secretion in response to an intraperitoneal (IP) 
injection of glucose (glucose tolerance test, GTT) was also increased in the mutant mice 
and consequently glucose tolerance was increased.  Histological and immunochemical 
analyses of the pancreases of the Esp-/- mice revealed increases in insulin content, size 
and number of islets, and β-cell mass [8].  Therefore, these results showed for the first 
time that a gene expressed primarily by bone has a large impact on whole body glucose 
metabolism. 
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An increase in circulating insulin alone may not be effective in decreasing blood 
glucose, since T2D is characterized by a decrease in hepatic and peripheral insulin 
sensitivity, typically in the presence of elevated, compensatory, circulating insulin 
concentration [30].  However, Esp-/- mice had both an elevated fasting insulin 
concentration, and an increase in insulin sensitivity compared to wild-type (WT) mice 
when measured by an insulin tolerance test (ITT) [8].  Hyperinsulinemic euglycemic 
clamps confirmed that the mutant mice required a 50% increase in glucose infusion rate 
to maintain euglycemia compared to their WT littermates, further establishing the 
increased insulin sensitivity in the Esp-/- mice [8].  The increased infusion rate was due 
to an increase in glucose uptake of the muscle and white and brown adipose tissue.  
Adiponectin, a protein secreted by white adipose tissue, has been shown to increase 
insulin sensitivity [31] and Esp-/- mice showed an increased gene expression in fat and 
serum levels of adiponectin [8].  This suggested that bone can communicate with 
adipose tissue to affect insulin action in insulin-sensitive tissues such as skeletal muscle. 
Esp-/- mice were also studied using two different models of obesity: 
goldthioglucose (GTG) induced and high-fat diet (HFD) induced obesity.  The 
inactivation of Esp was able to correct the metabolic abnormalities typically seen in 
these forms of obesity.  While injection of GTG into WT and Esp-/- mice resulted in 
hyperphagia, only the WT+GTG mice gained significant body weight compared to 
those not injected with GTG.  Knockout of Esp was also able to spare the mutant mice 
from the resultant increase in fat mass, serum triglyceride concentration, and glucose 
and insulin intolerance.  Similar metabolic protection occurred in the HFD-induced 
obesity model with Esp inactivation [8]. 
11 
Another series of experiments by the same investigators using a gain-of-function 
approach by overexpression of the osteoblast-specific Esp gene, further demonstrated 
the role osteoblastic expression of Esp on whole-body glucose metabolism.  Esp 
overexpression resulted in an opposite metabolic phenotype to that seen in the knockout 
experiments.  Overexpression of Esp within the osteoblasts resulted in decreased β-cell 
proliferation and mass, decreased insulin concentration following feeding, along with 
impaired insulin secretion in response to glucose injection, and decreased adiponectin 
concentration [8].  Co-culturing osteoblasts with pancreatic islets from WT mice 
increased Insulin expression with a greater increase occurring in Esp-/- osteoblasts [8].  
Co-culture of WT osteoblasts with WT adipocytes increased Adiponectin expression 
within the adipocytes and, in support of the earlier evidence that Esp-/- mice had 
increased serum adiponectin concentration, Esp-/- osteoblasts were able to double this 
increase in expression.  It was determined that the increases in Insulin and Adiponectin 
expression were a result of a molecule that is secreted by the osteoblasts since the 
expression of these genes were increased even when separated during co-culture. 
Since Ocn-/- mice had been recognized previously as being abnormally fat, 
subsequent research addressed whether OC is a molecule secreted from osteoblasts that 
regulates glucose homeostasis under the control of Esp [8].  The serum of Ocn-/- mice 
had decreased insulin and adiponectin while their serum glucose and triglyceride 
concentration was increased.  These mice also demonstrated impaired glucose tolerance 
and insulin secretion.  Additionally, islets size and number and β-cell mass and 
proliferation were decreased while their adipocyte number and fat mass were both 
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increased.  Thus, Ocn-/- mice were phenotypically opposite of those mice with 
inactivation of Esp. 
Similar to the co-culture studies of Esp-/- osteoblasts, Ocn-/- osteoblasts were 
put in co-culture with WT islets or adipocytes; however, unlike the WT or Esp-/- 
osteoblasts, Ocn-/- osteoblasts were unable to induce expression of either Insulin or 
Adiponectin in the islets or adipocytes, respectively [8].  Overexpression of Osteocalcin 
was able to increase the expression of Insulin and Adiponectin; moreover, addition of 
recombinant Osteocalcin to fibroblasts co-cultured with β-cells was able to induce 
expression of Insulin in these cells.  These culture studies were supported by in vivo 
experiments subjecting Ocn-/- mice to a GTT where half of these mice were injected 
with glucose only and half received glucose plus 20ng of OC [8].  As discussed earlier, 
the Ocn-/- mice were glucose and insulin intolerant; however, those injected with 
recombinant OC were able to tolerate the glucose load similar to WT mice and insulin 
secretion was significantly increased compared to those mice injected with the vehicle 
treatment.  This finding demonstrated that OC plays a primary role in glucose 
metabolism. 
Since Esp-/- and Ocn-/- mice display opposite metabolic phenotypes, it was 
hypothesized that these two genes must lie along the same metabolic pathway.  In fact, 
deletion one allele of the Ocn gene in Esp-/- mice reversed the metabolic advantages 
that were shown in previous experiments [8].  Interestingly, the serum levels of OC 
were unaffected by Esp knockout, which led to the proposal that OST-PTP may affect 
osteocalcin activity and not production.  To address this possibility, Karsenty’s group 
examined whether the effect of OST-PTP on OC was to promote the post-translational 
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γ-carboxylation of OC.  They took advantage of the binding affinity that cOC has to HA 
and discovered that, following incubation with HA, 16% less OC from Esp-/- mouse 
serum was bound to HA than OC measured in the serum from WT mice [8].  To further 
establish that it was the undercarboxylated form of OC that regulated glucose 
metabolism, WT osteoblasts were treated with warfarin, known to inhibit γ-
carboxylation [32], and this treatment resulted in a decrease in the amount of OC bound 
to HA [8].  These warfarin-treated osteoblasts were more potent in inducing the 
expression of Adiponectin.  Also, only uOC, produced by bacteria, was able to induce 
expression of Insulin and Adiponectin in islets and adipocytes, respectively [8].  
Summarizing their findings, the authors stated since Esp-/- did not develop obesity or 
diabetes and were resistance to glucose intolerance and insulin resistance that the 
skeleton may act as a key regulator of energy metabolism and contribute to the 
development of the metabolic syndrome. 
So throughout the study by Lee et al. [8], Karsenty and colleagues had shown 
that the bone was a key regulator of glucose metabolism through their ingenious Esp-/- 
mouse model since Esp is an osteoblast specific gene. Subsequently, through their co-
cultures of osteoblasts with islet and adipocyte cells, they established that there must be 
an osteoblast specific protein that is being released from these Esp-/- cells influencing 
adiponectin and insulin.  They turned back to their observation of Ocn-/- mice being 
abnormally fat and established that OC was the protein responsible.  Further 
investigation showed that Esp did not regulate the production of OC but was 
responsible for reduced carboxylation of OC, which in turn increased the ability of OC 
to improve glucose metabolism. 
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A key characteristic of hormonal regulation is that an endocrine organ secretes 
hormones to act on other tissues and also receives information from the affected tissue 
as part of a feedback loop.  Since they were able to show that OC secreted from 
osteoblasts was able to affect insulin release by the pancreas, Karsenty’s research group 
began to examine if insulin could then affect the osteoblasts, and thereby form a 
feedback loop.  The interaction of insulin with its receptor (InsR) results in a 
phosphorylation of the receptor.  Building off of the previous studies of Esp-/-, 
Karsenty and colleagues conducted experiments that determined that OST-PTP was 
able to dephosphorylate, meaning deactivate, InsR and that Esp-/- osteoblasts showed 
increased phosphorylation of the InsR [33].  They were then able to generate a mouse 
model with an osteoblast-specific knockout of InsR and these mutant mice had 
decreased insulin secretion in response to a glucose challenge, increased postprandial 
blood glucose, and glucose and insulin intolerance.  This mutant model demonstrated 
that insulin signaling within the osteoblast had a significant effect on whole-body 
glucose homeostasis.  Following these observations, Karsenty and colleagues proposed 
that, since OST-PTP has an influence on insulin signaling and OC activity within the 
osteoblasts, these two must lie in the same metabolic pathway as well.  To prove this 
hypothesis they showed that mice with impaired insulin signaling in osteoblasts due to 
the loss of one allele of InsR had decreased uOC levels and that Esp-/- mice had an 
increase in uOC and increased insulin signaling in osteoblasts [33].  Additionally, they 
found that InsR-/- mice had a decrease in bone resorption markers while the Esp-/- mice 
had an increase in these markers.  Combining these observations and the knowledge that 
bone resorption results in an acidic pH in the bone matrix, which can decarboxylate 
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proteins [34], the authors theorized that bone resorption may regulate the carboxylation 
of OC.  To test this hypothesis, the authors incubated fully carboxylated OC in a 
solution that had a pH 4.5 to replicate the pH of resorption lacunae and this resulted in a 
2-fold increase in decarboxylation compared to cOC incubated in a pH 7.5.  
Additionally, they cultured osteoclasts on cortical bone slides and reported that when 
osteoclast differentiation was triggered there was a 2-fold increase in the uOC/OC ratio 
[33].  Subsequently, the authors used a mouse model that had a decreased ability to 
acidify the bone extracellular matrix and found that these mice showed similar 
metabolic characteristics as Ocn-/- mice.  Importantly, the Esp gene in mice is just a 
pseudogene in humans, so there is concern that some results may not be fully 
generalizable.  However, the finding that the insulin receptor was a substrate for the 
protein encoded by Esp (OST-PTP) was used to identify that the human protein 
involved in insulin signaling in the osteoblasts was protein-tyrosine phosphatase 1B 
(PTP1B) [33].  The same authors also reported that human patients with a defect in 
bone resorption had decreased concentration of circulating uOC and decreased serum 
insulin following feeding [33].  Therefore, the major findings of this study were that  
the osteoblast secretes OC, osteoclast activity decarboxylates OC, insulin signaling in 
the osteoblasts is a key regulator in whole body glucose homeostasis, and PTP1B is the 
human protein within the intracellular insulin signaling pathway that can regulate OC 
activity [33]. 
To confirm an in vivo role for OC in glucoregulation, the same research group 
first implanted 8-week old WT mice with pumps that delivered OC in amounts of 0.03, 
0.3, 3 and 30 ng/h for 4 weeks [35].  Ferron et al. established that mice receiving OC in 
16 
doses or 0.3 and 3 ng/h had significantly lower blood glucose and increased insulin 
levels than those receiving a vehicle.  They also reported that the mice receiving 0.3 or 
3 ng/h had greater tolerance to glucose and insulin sensitivity than mice receiving 
vehicle.  Subsequently, they implanted mice with pellets that released 3 ng/h of OC and 
fed them a high-fat diet for 8 weeks to examine if this exogenous dose of OC could 
counteract the negative metabolic effect seen in diet-induced obesity.  They reported 
that the mice receiving OC treatment gained significantly less weight, had smaller fat 
fad, normal triglyceride levels, had improved glucose tolerance and were more insulin 
sensitive than mice fed a high-fat diet without OC treatment [35].  Based on the results 
from their previous study, Ferron et al. [36] subsequently investigated whether daily 
injections with recombinant OC at doses of 3 or 30 ng/g/day would improve glucose 
handling by 8-week old WT mice.  While mice injected with OC did not differ in body 
weight during the 16 weeks of treatment, following 5 weeks of treatment, and 
continuing throughout the treatment period, the 30 ng/g/day dose resulted in reduced 
blood glucose compared to mice receiving a vehicle injection.  Glucose tolerance tests 
performed at both 4 and 8 weeks of treatment revealed that both doses were able to 
improve glucose clearance (in a dose-dependent manner) and insulin sensitivity 
following 4 weeks of treatment.  Following the full 16 weeks of treatment with OC the 
WT mice had, dose-dependent increases in insulin secretion to a glucose challenge and 
increased β-cell mass.  These results established that the 30 ng/g/day dose was the most 
effective for improving glucose metabolism.  To further establish the therapeutic effect 
of exogenous OC, Ferron et al. [36] put 8-week old mice on a high-fat diet for 8 weeks 
to induce insulin resistance and dysglycemia.  Following the 8-week high-fat diet the 
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mice were injected with 30 ng/g/day for 8 weeks.  Injection of OC resulted in partial 
normalization of FPG and the glucose intolerance compared to mice injected with a 
vehicle following just a month of treatment.  Additionally, insulin sensitivity was 
increased and fasting serum insulin decreased by 70% in mice receiving OC compared 
to the vehicle-injected mice following 8 weeks of treatment.  Interestingly, while food 
intake and physical activity were similar in the vehicle- and OC-injected mice, the mice 
injected with OC had significantly lower body weight and fat mass that was attributed 
to increased energy expenditure and heat production [36].  These results suggested that 
OC was able to reduce body weight gain resulting from a high-fat diet by increasing 
energy expenditure.  Morphological analysis of the skeletal muscle of OC injected mice 
revealed greater mitochondrial mass compared to vehicle injected mice, which provides 
a plausible mechanism through which excess energy could have been dissipated rather 
than accrued as stored lipids [36]. 
This series of experiments done by Karsenty and colleagues established that OC 
plays a major role in the regulation of glucose metabolism and energy expenditure and 
that insulin plays a key role in the bioavailability of OC via a feedback loop .  In a 
recent review [37], Karsenty stated: 
“Altogether, the metabolic functions of osteocalcin and their regulation by leptin 
and insulin reveal how intertwined energy metabolism and bone (re)modelling 
are. They also underscore the importance of the interplay between osteoblasts 
and osteoclasts for glucose metabolism and indicate that the regulation of 
osteocalcin activity occurs at both the transcriptional and post-translational 
levels.” 
Subsequently, Karsenty and Ferron [37] proposed several future directions of research 
on OC  and its role as a regulator of glucose metabolism.  While their research team led 
the way in establishing the bone as a key factor in energy homeostasis and the role that 
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OC plays in metabolism, much of their research conducted in mice needs to be verified 
in humans.  Human studies will help establish whether the results from studies of mice 
are generalizable among species and the role of OC in human glucose regulation 
  
Figure 1. Proposed release and action of OC.  Adopted from Ferron et al. [33]. 
 
 
Associative studies of Osteocalcin in Humans 
Obesity was long thought to have a protective effect on bones [38-42]; however, 
growing evidence shows that obesity has may actually be associated with low bone 
mineral content and density, as well as an increased risk for osteoporosis, osteopenia, 
and non-spinal fractures [43-46].  Early cross-sectional research showed that OC was 
associated with improved glucose metabolism and insulin sensitivity [10, 11, 47-49].  
For example, in older adults (age >65), serum OC was inversely associated with fasting 
plasma glucose (FPG), insulin, homeostatic model assessment-insulin resistance 
(HOMA-IR), C-reactive protein, BMI and body fat [12].  These authors also reported 
that, over a 3 year period, average serum OC was inversely related to the increase in 
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FPG, which suggests that higher level of OC may be a marker of decreased diabetes risk 
in older people.  In support of these findings, Kindblom et al. [11] showed an inverse 
correlation with fasting OC and BMI, fat mass, FPG and HOMA-IR in a group of 
>1,000 elderly Swedish men.  In those men, plasma OC was a significant predictor of 
blood glucose, even when controlling for serum insulin, triglycerides, and body 
composition.  In the subset of men with diabetes in that study, approximately 15% of 
group, circulating OC was 20% lower than the men without diabetes.  The Japanese lab 
of Ippei Kanazawa also conducted a series of cross-sectional studies that revealed that 
total serum OC was positively associated with insulin sensitivity and secretion while 
negatively correlated with FPG, HOMA-IR and hemoglobin A1C (HbA1C) in men and 
women with T2D [48].   Consistent with the hypothesis that uOC is the active isoform 
of OC in regulating glucose metabolism the same authors also reported that uOC was 
negatively associated with FPG and HbA1C while the ratio uOC/OC was positively 
correlated with BMI, and visceral and subcutaneous fat area in men with T2D [49].  
Furthermore, serum OC was positively correlated with brachial-ankle pulse wave 
velocity (baPWV) and intima-media thickness (IMT), which are measures of 
atherosclerotic risk, in men with T2D [10]. 
In agreement with the studies in middle-aged or elderly people, recent research 
in younger populations supports that OC is associated with multiple components of 
glucose metabolism and insulin resistance [50, 51].  For example, a study of young 
adults (17-22 years) showed that total OC, but not uOC, was inversely associated with 
BMI, waist circumference and systolic blood pressure [52].  A few larger cohort (N=84-
1768) studies that included people who were 19-82 years old reported that total OC was 
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negatively associated with visceral fat area [51, 53] and improved glucose tolerance and 
insulin secretion and sensitivity [54].  In addition, Lucey et al. [50] reported that young 
(age 20-40 years) women with less lean body mass (LBM) had lower total OC along 
with high C-reactive protein (CRP), fasting glucose, insulin and HOMA-IR compared 
to similar size women.  Additionally, women in the lowest tertile of total OC were 
highest in CRP and men in the lowest tertile of uOC had double the concentration of 
CRP than men in the higher tertiles.  These results combined show that even in young 
adults OC and uOC may play a role in glucose metabolism, insulin resistance and 
inflammation associated with obesity. 
Over the past four decades obesity prevalence in adolescence has been on the 
rise and this sharp rise requires researchers and practitioners to develop effective 
lifestyle interventions that incorporate exercise, nutrition or both, to prevent or reverse 
the metabolic dysfunction that often accompanies obesity.  Establishing a marker of 
insulin resistance that is responsive to changes in diet and physical activity may be 
valuable to understand the mechanisms of obesity and inactivity-induced insulin 
resistance and to monitor effects of specific interventions.   Further study of OC may 
serve either of those purposes.  In support of the results from studies with adults, 
Boucher-Berry et al. [55] reported serum OC level was associated with components of 
body composition and biochemical markers in 106 middle school children.  Total serum 
OC was inversely related to BMI, percent body fat and fat mass, while being positively 
associated with FPG in the total group of children.  Pollock et al. [13] compared serum 
OC and OGTT measures of 41 overweight, prediabetic children compared to 99 
children who were also overweight but had normal glucose measures.  While there were 
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no differences reported between the groups for BMI percentile, percent body fat, 
physical activity levels, or subcutaneous abdominal adipose tissue, the prediabetic 
children had significantly lower total OC (15%) and uOC (28%).  Additionally, 
although not significant, children with prediabetes had a decreased percentage of OC 
that was decarboxylated.  Results from multivariate analysis, using age, sex, race and 
visceral adipose tissue as covariates, revealed that cOC was positively associated with 
insulin sensitivity and negatively associated with fasting insulin in the children with 
prediabetes while uOC was positively associated with both insulinogenic index and 
disposition index.  These results suggest that while cOC may influence glucose 
homeostasis, uOC may play more of a role in β-cell dysfunction [13]. 
Not all studies with children are in agreement, however.   Rochefort et al. [56] 
found that fasting concentrations of serum OC and uOC did not differ between obese 
and non-obese prepubertal children.  Furthermore, in a study of 497 healthy German 
children, Flemming et al. [57] showed that while serum OC was associated with 
pubertal development and peaked at Tanner stage 3, there was no significant association 
with BMI.  The only significant difference in OC between overweight/obese children 
and their normal weight counterparts occurred in early puberty (combined Tanner 
stages 1 and 2).  However, the authors reported a significant positive correlation 
between serum OC and waist-to-hip ratio, specifically in those children in late puberty 
(combined Tanner stages 4 and 5) [56]. 
These results indicate that OC may be a marker of dysfunctional glucose 
metabolism in elderly and young adults and it could also be an effective early marker in 
children and adolescents.  While the exact mechanisms by which OC may affect 
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glucose metabolism in humans and the isoform that is most active within the 
glucoregulatory pathway in humans is yet to be established, the cross-sectional results 
support a need for further investigation about whether and how OC responds to 
nutritional and physical activity interventions.  Such studies should result in better 
understanding about the potential role of changes in circulating OC or uOC and glucose 
metabolism in humans. 
Table 1.  Summary of literature from human studies that report association 
between OC and selected metabolic risk factors. 
 OC uOC cOC 
Obesity (BMI) Negative (4 studies) Inconclusive Negative (1 study) 
Type 2 diabetes Negative (3 studies) Negative (1study) Unknown 
Fasting glucose Negative Negative (2 studies) Unknown 
Fasting insulin Negative Negative (2 studies) Unknown 
HOMA-IR Negative Inconclusive Negative (1 study) 
Insulin sensitivity Positive Positive Unknown 
 
Effects of Exercise or Nutrients on Osteocalcin 
The reduction in cardiovascular risk associated with an increase in physical 
activity has been well documented.  One of the physiological responses to exercise is 
enhanced insulin sensitivity and glucose uptake [14].  While many mechanisms for this 
response have been postulated, the underlying regulatory events have not yet been 
elucidated.  Interestingly, perfused muscles of rats [14] and muscle extracted from rats 
following exercise [58] showed increased insulin sensitivity; however, muscles that 
were washed and then contracted in vitro did not show the same enhancement in insulin 
sensitivity [15].  This suggests that a circulatory protein may potentiate insulin action on 
skeletal muscle. Given its influence on insulin secretion and sensitivity and that exercise 
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increases bone formation [reviewed in 59, 60], it has been hypothesized that OC may be 
the missing serum protein that can link exercise to changes in insulin sensitivity [61]. 
The effects of exercise on serum OC and the association that these changes may 
have on glucose metabolism have not been as well documented in the literature at this 
time.  However, measurement of serum OC as a marker of bone formation following 
exercise has been well characterized.  Nishiyama et al. [62] reported that athletic 
individuals had increased serum OC compared to those with lower physical activity.  
Additionally, 30 minutes of running at ~50% maximal workload resulted in a significant 
increase (58%) in serum OC in less athletic individuals immediately following exercise, 
while the athletes actually had an 11% reduction in serum OC.  Conversely, 60 minutes 
following cessation of exercise, the athlete group had a 17% increase from baseline 
(32% from immediately after exercise) in serum OC whereas the non-athlete group only 
showed an 11% increase from baseline (-30% from immediately following exercise) 
[62]. 
Additionally, in recreationally trained young males, a low-intensity cycling bout 
(45 minutes at 55% VO2max) resulted in no changes in serum OC 4 hours following the 
cessation of exercise while both higher intensity cycling (15 minutes at 85% VO2max) 
and strength exercise (5 sets of 8 repetitions at 85% 3RM) resulted in a decrease in OC 
at the 4-hour post-exercise time point [63].  Rong et al. [63] reported that the absolute 
concentration of OC wasn’t increased following the low-intensity cycling bout, 
although there was a small relative increase when compared to the control (no exercise), 
in which OC declined post-exercise.  Since the study began at 0700-0800, the control 
condition of their study showed the diurnal decrease at noon stated previously; 
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therefore, when comparing the exercise conditions to the control condition, the high-
intensity cycling and strength exercise resulted in no effect on OC while low-intensity 
cycling was able to maintain steady OC concentrations, counteracting the typical early 
afternoon trough [63]. 
Maïmoun et al. [64] had 7 male cyclists perform 50 minutes of cycling at either 
15% below or 15% above their ventilatory threshold (VT).  Contrary to the findings of 
Rong et al. [63], the longer duration of the high-intensity bouts conducted in this study 
resulted in increased serum OC [64].  Cycling at -15% of VT resulted in a 7.8% 
increase in serum OC (not significant); while an intensity of +15% of VT resulted in a 
significant 12% increase immediately upon cessation of exercise.  Interestingly, the 
authors reported that serum OC returned to baseline within a 15-minute recovery period 
following exercise.  Taken together these data suggest that exercise intensity may play 
an important role in OC production. 
Not all reports on serum OC following exercise are in agreement however; 
Tosun et al. [65] examined serum OC in young women immediately and 15 minutes 
following either brisk walking or similar exercise (60-85% age-predicted maximal heart 
rate) carrying a 5kg weight in a backpack.   The within-subject statistical analysis 
revealed that there was no significant difference between the exercise bouts and the 
resting measurements of serum OC.  Additionally, a similar non-weighted exercise 
stimulus was unable to affect circulating OC at 1, 8, 16, 24, or 32 hours post-exercise in 
10 healthy young (age 20-35) men [66].  The combination of the above results could 
indicate that serum OC is affected by the training status of the individual and the 
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intensity of the exercise stimulus involved.  Also, post-exercise variations in serum OC 
could differ depending on the timing of the obtainment of the serum sample. 
In addition to the above acute studies utilizing OC as a marker of bone 
formation, Hinton et al. [67] studied 19 overweight subjects during a 6 week weight loss 
intervention examining changes in OC with aerobic exercise.  Their results revealed that 
while weight was reduced by ~5%, normally resulting in decreases in bone formation 
[68, 69], the addition of aerobic exercise was able to neutralize these theorized 
decreases, and increase OC by 18.5% while increasing bone alkaline phosphatase 
(BAP), another marker of bone formation [67]. 
While the previous studies investigated changes in OC in response to exercise, 
most were examining serum OC only as a marker of bone turnover.  Fernández-Real et 
al. [47] conducted three separate studies to examine the associations of OC on people 
without diabetes and if weight loss, either through diet alone or diet and exercise, has a 
significant effect on these concentrations.  Their cross-sectional study of healthy, 
middle-aged people supported the findings suggested earlier that circulating OC was 
positively associated with insulin sensitivity (calculated by HOMA-IR).  The authors 
also examined the effect of weight loss achieved either with diet alone (-500 kcal/day) 
or diet with the addition of a structured resistance exercise program on circulating OC 
and insulin resistance in 26 obese female subjects.  While weight loss (~7-8%) alone 
had no effect on serum OC, a structured resistance training program along with diet 
resulting in a similar degree of weight loss resulted in increased serum OC [47].  
Corresponding to these increases in serum OC for the diet plus resistance training group 
were decreases in visceral adipose tissue (r= -0.53) and increases in leg strength (r= 
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0.69).  While the diet plus resistance training group experienced increases in leg 
strength and no change in thigh muscle mass, the diet only group saw a decrease in 
thigh muscle mass.  For the entire group the changes in visceral adipose tissue was 
determined to be the greatest predictor of change in OC in multiple regression analysis 
when the authors controlled for age, BMI, and HOMA-IR; when leg muscle strength 
was added to the model, both change in visceral adipose tissue and change in leg muscle 
strength accounted for 30% of the variation in OC [47].  In addition to these studies, 
Fernández-Real and colleagues examined if double the weight loss (~17%) could result 
in greater changes to circulating OC.  In the 20 obese (average BMI = 38.0) subjects 
studied, they did report a significant increase in serum OC; however, the increase in OC 
showed no significant associations with changes in insulin resistance, measured by the 
quantitative insulin sensitivity check index (QUICKI) [47].  Fernández-Real and 
colleagues showed that moderate (~17%) but not slight (~7%) diet-induced weight loss 
can increase serum OC levels and this finding may indicate that there is a threshold of 
weight-loss that is needed to show the changes in bone turnover that are induced by 
weight loss that have been previously reported [reviewed in 70].  The most intriguing 
finding in their studies seemed to be that resistance exercise training and diet resulting 
in similar slight weight loss can also significantly increase circulating OC.  A possible 
explanation for this is that increased total serum OC is only indicative of increased bone 
turnover and that uOC has been more closely linked with changes in glucose 
metabolism [8] so the percentage of uOC could differ between the diet only weight loss 
and the diet plus exercise induced weight loss. 
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In addition, Levinger et al. [71] investigated the changes in serum OC following 
either an acute aerobic or an acute resistance exercise bout and how these changes may 
associate with changes in glucose metabolism.  They studied 28 middle-aged, obese 
men, randomly assigned to perform either 45-minutes of cycling at a heart rate 
corresponding to 70-75% VO2max or an acute power exercise bout, 2 x 5 sets 70-75% 
1RM leg press with a jumping routine completed between each five sets.  Both OC and 
uOC was significantly increased by the acute aerobic exercise bout, while the acute 
power exercise bout showed no significant increase in either OC or uOC.  These authors 
also performed a sub-analysis of subjects with T2D and found that exercise, pooled 
aerobic and power, was able to increase uOC by 4.4% and this change in uOC was 
positively correlated with changes in blood glucose concentrations following the  
exercise bout [71].   
Since insulin has been shown to have an effect on bone remodeling [33] and 
insulin signaling in mice has been shown to increase OC activity, it would be 
reasonable to believe that factors increasing insulin would in turn effect circulating OC.  
An oral glucose tolerance test (OGTT) is a common clinical test conducted to examine 
the glucose clearance rate by the body following ingestion of 75 grams of glucose, 
typically done to test for possible T2D [72].  Paldánius et al. [73] recently examined the 
effect of an OGTT on circulating OC concentrations in 23 healthy subjects.  Following 
(2 hours) the consumption of 75 grams of glucose, serum OC decreased by 32.1% and 
cOC decreased by 34.4%.  The authors also reported that these changes in serum OC 
and cOC were not associated with changes in insulin or glucose at this 2-hour time 
point [73]. 
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Previous studies have suggested that people with the lowest basal level of OC 
have the greatest increase in OC following exercise [74].  Since other studies have 
shown that overweight individuals have decreased serum OC compared to their normal 
weight counterparts, this suggests that overweight people may experience the biggest 
change in OC in response to an exercise bout.  Consistent with this possibility, obese 
prepubertal children that underwent a 6-month training program consisting mostly of 
aerobic activities (i.e. cycling, rowing, jumping) demonstrated an increased whole-body 
bone mineral density (WB-BMD) compared to comparable children without training 
[56].  Additionally, Rochefort et al. reported increases in serum OC (27%) and serum 
uOC (37.7%) following 6 months of physical training by obese children.  These results 
also indicated a 3.4% increase in the percentage uOC/OC from 39.3% to 42.7%.  In 
another study  obese children had lower OC compared to normal weight peers and 
completed a year-long weight loss intervention involving of exercise, behavior 
modification and nutrition therapy [75].  The weight-loss program resulted in increased 
serum OC, which was related to decreased HOMA-IR, BMI and leptin.  In a subset of 
the obese children, the authors pointed out that 29 of the 60 achieved substantial weight 
loss, “defined as a reduction in BMI standard deviation score of ≥ 0.5, because only 
with a reduction of > 0.5 in SDS-BMI was an improvement in insulin resistance 
measured in obese children” [75].  Children who had substantial weight loss also had a 
significant increase in OC, while those without substantial weight loss did not 
demonstrate a significant elevation in OC.  The children with substantial weight loss 
also had significant reductions in HOMA-IR and leptin concentration following the 
weight loss program [75]. 
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Table 2.  Summary of studies on OC responses to exercise in humans. 
 
OC uOC cOC 
Acute exercise   
Unknown 
Exercise training 
Inconclusive Unknown Unknown 
 
In summary, OC is produced by the osteoblasts and is one of the most abundant 
proteins found within the circulation.  It is released into circulation in two distinct forms 
determined by the carboxylation status, fully carboxylated and undercarboxylated.  It 
was recently discovered that OC plays a role in glucose metabolism by increasing 
insulin secretion by the β-cells and increasing insulin sensitivity of the peripheral 
tissues.  Serum OC increases following an acute exercise bout and these changes may 
be influenced by differing intensity, duration and mode of exercise along with the 
training status and sex of the population studied.  Additionally, longer duration 
interventions have shown that weight loss achieved by increases in physical activity 
result in increased circulating OC and the changes in OC are inversely associated with 
reduction in HOMA-IR.  While exercise has been shown to increase circulating OC, 
glucose intake has been shown to decrease serum OC in an acute timeframe following 
ingestion. 
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Chapter III: Methods 
 
Subjects 
15 overweight or obese young men (18-25 years old) males were recruited to 
participate.  Eligibility inclusion criteria include the following: 1) subjects were 
overweight as defined by a BMI 25-35 kg/m
2
, 2) subjects were not physically active for 
> 1 hour/week, 3) subjects did not have any cardiometabolic disorders including 
diabetes, heart disease, arrhythmias, thyroid disease, or hypogonadism, 4) subjects were 
free of any diseases known to result in decreased bone mineral density. 
 
Research Design 
A two-way [intervention (resting vs. exercise) x time (0, 30, 60, 90, 120 
minutes)] repeated measures design was utilized to determine the acute effects of 
exercise or nutrition on OC and glucose metabolism.  All subjects reported to the lab on 
3 separate occasions [screening, oral glucose tolerance test (OGTT), exercise prior to 
OGTT (EX)] with at least four days between visits.  During the first visit, subjects 
completed the informed consent forms and were informed of all the requirements to 
participate in the study.  Subjects were then verbally and medically screened to ensure 
that they met the inclusion criteria. These steps were followed by measurement of body 
composition using Dual Energy X-Ray Absorptiometry (DXA) and a maximal aerobic 
capacity test (VO2max).  During each subsequent visit, subjects arrived at the laboratory 
between 0800 and 0830 following a 10-hour fast and completed one of the two testing 
protocols in predetermined random order.  During the OGTT visit, subjects rested in a 
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seated or supine position and an intravenous catheter was inserted in a forearm or hand 
vein and kept patent with saline infusion for serial blood sampling.  A blood sample was 
drawn and designated as the first time point (T0).  Following T0, subjects consumed a 
75 gram oral glucose load (296 mL; Thermo Scientific, Middletown, VA) within 5 
minutes and subsequent blood collections occurred again 30, 60, 90, and 120 minutes 
after completion of the drink (T30, T60, T90, and T120, respectively).  During the EX 
visit, subjects completed a 5-minute warm-up followed by 4 blocks of exercise 
consisting of 4 minutes at ~90% maximal heart rate (HRmax, actual: 78-89%) with 3 
minute active recovery at a workload eliciting ~65% HRmax, and a 6-minute cool-down 
(36 minutes total, average HR for entire workout: 77 ± 5% max).  A high-intensity 
interval exercise bout was chosen due to previous research showing greater long-term 
improvements in insulin signaling utilizing this method compared to moderate 
continuous moderate exercise [76].  Within 10 minutes of cessation of exercise, subjects 
had an intravenous catheter inserted in a forearm or hand vein and underwent the same 
procedures as the OGTT visit.  The timing of each test was adjusted so that the 
ingestion of the glucose load consistently occurred around  0900 and T30 consistently 
occurred around 0930 among trials to account for the diurnal variations in serum OC in 
young adults [27].  Study design is shown in Figure 2. 
Figure 2. Study Design. 
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Variables 
The independent variables studied were the interventions performed (resting and 
exercise).  The dependent variables studied were: 
Carboxylated Osteocalcin – Serum carboxylated OC was quantitatively 
determined using a commercially available enzyme immunoassay (EIA) kit (Gla-type 
Osteocalcin EIA kit, Cat. #MK111, Clontech laboratories, Inc., Mountain View, CA).  
Briefly, 100 µL of serum samples along with a 6-point serial dilution standard (16-0.25 
ng/mL) was added, in duplicate, to a microtiter plate that had each well coated with 
murine monoclonal antibody to Gla-OC.  The plate was incubated at room temperature 
for 2 hours on an orbital shaker at 150 revolutions per minute.  Following incubation, the 
wells were decanted and washed three times with 400 µL of wash buffer [phosphate-
buffered saline (PBS)] using a plate washer (Wellwash 4 MK 2, ThermoFisher 
Scientific, Inc., Waltham, MA).  100 µL of antibody-POD conjugate (horseradish 
peroxidase conjugated murine monoclonal antibody to OC) was added to each well 
using an 8-channel pipette and incubated for 1 hour at room temperature on an orbital 
shaker.  Following this incubation, mixtures were decanted and wells were washed 4 
times with the washing buffer.  Following wash, 100 µL of substrate solution (hydrogen 
peroxide and tetramethylbenzidine in a buffered solution) was added to each well using 
an 8-channel pipette and plate was allowed to incubate at room temperature for 15 
minutes on an orbital shaker.  Subsequently, 100 µL of stop solution (1N H2SO4) was 
added to each well and mixed to stop the reactions.  The plate was mixed by hand and 
the absorbance was read using a microtiter plate reader (Synergy 2 with Gen5 software, 
Biotek Instruments, Inc., Winooski, VT) at 450 nm using distilled water as a control to 
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make zero adjustment.  The absorbance of the samples was plotted using the standard 
curve for quantitative determination of the concentration of carboxylated OC.  In order 
to reduce the bias by inter-assay variability, samples for each subjects (OGTT and EX) 
were analyzed on the same microtiter plate.  Intra- and inter-assay precision 3% and 
3%, respectively.  The manufacturer reports that this assay had no detectable cross 
reaction with decarboxylated OC. 
Undercarboxylated Osteocalcin – Serum uOC was quantitatively determined 
using a commercially available enzyme immunoassay (EIA) kit (Undercarboxylated 
EIA kit, Cat. #MK118, Clontech laboratories, Inc., Mountain View, CA).  Briefly, 
samples were first diluted 1:1 with sample diluent. 240 µL of diluted serum samples 
along with a 6-point serial dilution standard and blank (dH2O) were added to an 
untreated microtiter plate. The samples, standards and blank were then transferred 
(using an 8-channel pipette so to ensure the entire plate was loaded in <5 minutes) to a 
supplied microtiter plate on which each well was coated with anti-Glu-OC monoclonal 
antibodies.  The plate was incubated at room temperature on an orbital shaker at 150 
revolutions per minute for 2 hours.  Following incubation, the wells were decanted and 
washed three times with a washing buffer [phosphate-buffered saline (PBS)] using a 
plate washer.  Plate was decanted and tapped on absorbent cloth following the wash.  
100 µL of antibody-POD conjugate (horseradish peroxidase conjugated murine 
monoclonal antibody to OC) was added to each well using an 8-channel pipette and 
incubated for 1 hour at room temperature on an orbital shaker at 400-500 revolutions per 
minute.  Following this incubation, mixtures were decanted and wells washed 4 times 
with the washing buffer using the plate washer.  Plate was decanted and tapped on 
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absorbent cloth following the wash.  100 µL of substrate solution (3,3’, 5,5’-
tetramethylbenzidine solution) was added to each well using an 8-channel pipette and 
plate was allowed to incubate at room temperature on an orbital shaker for 10-15 
minutes.  Subsequently, 100 µL of stop solution (1N H2SO4) was added to each well to 
stop the reactions.  Plate was mixed briefly on the orbital shaker at 400-500 revolutions 
per minute and within 10 minutes the absorbance was read using a microtiter plate 
reader at 450 nm using distilled water as a control to make zero adjustment.  The 
absorbance of the samples was plotted using the standard curve for quantitative 
determination of the concentration of uOC.  The calculated concentrations were then 
multiplied by a dilution factor (x2) for the final concentrations. In order to reduce the 
bias by inter-assay variability, samples for each subjects (OGTT and EX) were analyzed 
on the same microtiter plate.  Intra- and inter-assay precision 8% and 6%, respectively.  
Manufacturer’s measurement of uOC utilizing this EIA kit has been closely (r = 0.82) 
with a hydroxyapatite binding assay.  The manufacturer also states that this assay had 
5% cross reactivity with human bone OC (most likely carboxylated) and 1.7% cross 
reactivity with bovine bone OC (most likely carboxylated) so it is likely to overestimate 
the true concentration of uOC. 
Total Osteocalcin – Total serum osteocalcin was calculated by adding the 
measured carboxylated and undercarboxylated fractions of OC.  While this is not a 
direct measure of total osteocalcin, we utilized EIA kits for cOC and uOC from the 
same manufacturer (Clontech laboratories, Inc., Mountain View, CA) and the 
manufacturer states that the cOC kit has no detectable cross reaction with uOC and the 
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uOC kit has only a 5% cross reactivity with cOC.  Additionally, this approach has been 
utilized by previous authors [52]. 
Insulin – Serum insulin was measured using an enzyme-linked immunosorbent 
assay (ELISA) (Cat. #EZHIASF-14K, EMD Millipore, Billerica, MA) according to 
manufacturer’s directions.  Briefly, 300 µL of wash buffer (50 mM Tris buffered saline 
contained 200 µU/mL Tween-20) was added to each well and incubated at room 
temperature for 5 minutes before being decanted.  80 µL of assay buffer (0.05 M 
Phosphosaline, pH 7.4, containing 0.025 M EDTA, 0.05% ProClin300, and 0.1% Human 
Serum Albumin) was added to each blank and sample well and 60 µL of assay buffer was 
added to the standard curve wells and quality control (QC1 and QC2) wells.  Then, 20 μL 
of a matrix solution (treated human serum) was added to the blank, standard and quality 
control wells.  20 µL of the standard curve, QC1 and QC2 (purified recombinant human 
insulin in assay buffer), and samples were added to the wells in duplicate.  The plate was 
sealed with adhesive plate sealer film and incubated at room temperature for 2 hours on an 
orbital plate shaker at 400-500 revolutions per minute.  Solutions were decanted following 
incubation and plate was washed 3 times with 300 µL of wash buffer using the plate 
washer.  Plate was decanted and tapped on absorbent cloth following the wash.  
Subsequently, 100 µL human insulin ASF detection antibody (pre-titered biotinylated 
monoclonal insulin antibody) solution was added to each well and plate was sealed and 
incubated for 1 hour at room temperature with moderate shaking.  Following incubation, 
plate was decanted and washed 3 times with wash buffer as described above.  Plate was 
decanted and tapped on absorbent cloth following the wash.  100 µL of enzyme solution 
(streptavidin-horseradish peroxidase conjugate) was added to each well and plate was 
sealed and incubated for 30 minutes at room temperature on an orbital plate shaker.  
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Solutions were decanted following incubation and plate was washed 5 times with 300 µL of 
wash buffer using a plate washer.  Plate was decanted and tapped on absorbent cloth 
following the wash.  100 µL of substrate solution (3, 3’,5,5’-tetramethylbenzidine in buffer) 
was added to each well and plate was sealed and incubated at room temperature on the plate 
shaker for 5 minutes.  Following color development, 100 µL of stop solution (0.3 M HCl) 
was added to each well and plate was shaken by hand until solutions turned yellow.  
Absorbance was read at 450 nm within 5 minutes using a microtiter plate reader.  The 
absorbance values of the samples were plotted using the standard curve for quantitative 
determination of the concentration of insulin.  The sensitivity of the assay is 0.85 
µU/mL and range is 2-200 µU/mL. In order to reduce the bias by inter-assay variability, 
samples for each subjects (OGTT and EX) were analyzed on the same microtiter plate.  
Intra- and inter-assay precision was 6% and 2%, respectively. 
Glucose – Plasma glucose was measured by the glucose oxidase method 
(2300STAT Plus, Yellow Springs Instruments, Yellow Springs, OH).  Each sample was 
measured in duplicate and the average of the duplicates was used as the blood glucose 
concentration.  Intra-assay CV was 1%. 
Homeostatic Model Assessment–Insulin Resistance (HOMA-IR) – Fasting 
glucose and insulin values from OGTT visit were used to calculate the fasting insulin 
resistance.  The product of fasting glucose (mg/dL) and fasting insulin (µU/mL) was 
divided by 405 as previously described [77]. 
Oral Glucose Insulin Sensitivity (OGIS) – OGIS was calculated as described by 
Mari et al. [78].  Mari et al. reported that the OGIS calculation is in good agreement 
with glucose clearance as measured by Hyperinsulinemic-euglycemic glucose clamp 
and is as effective at establishing differences between groups (lean vs. obese, obese vs. 
37 
T2D) or relationships between insulin sensitivity and other physiological variables such 
as this study [78]. 
Anthropometry – Subject’s height and weight were measured using a 
stadiometer and electronic scale, respectively.  Body mass index (BMI) was calculated 
using the equation BMI = weight (kg) ÷ height
2
 (m).  Body composition was measured 
using Dual Energy X-Ray Absorptiometry (DXA) (Lunar iDXA, GE-Healthcare, 
Fairfield, CT).  Subjects were placed in the supine position with arms close to the side 
of the body and legs fastened together by a Velcro strap.  The scanner then passed over 
the entire body of the subject and the manufacturer software measured total body mass, 
total body fat mass, total body lean mass and total body bone mineral content.  Using 
the computer software, the total body masses were separated into regional (arms, legs, 
trunk) components for use in analysis. 
Blood Sample Collection and Storage 
Blood was collected with a 10mL syringe via an intravenous catheter and 
transferred to serum (red top) and glucose (gray top) tubes.  Tubes were inverted 5-10 
times (allowing the sodium fluoride to completely dissolve in the glucose tubes) and 
allowed to sit for at least 30 minutes (at room temperature for serum tubes and 4C for 
glucose tubes) prior to being centrifuged at room temperature at 1000 RCF for 10 
minutes in a fixed angle centrifuge.  500µL of serum and plasma was aliquoted into 
labeled microcentrifuge tubes for each variable (OC, uOC, insulin and glucose) so to 
avoid freeze/thaw cycles during analysis.  Samples were stored at -80°C until analyses 
were performed. 
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Statistical Analysis 
The Shapiro-Wilk statistic was determined for each dependent variable at each 
time point to ensure statistical normality.  Dependent variables that were skewed 
(Shapiro-Wilk statistic p < 0.05) were logarithmically transformed for further analysis.  
A two-way [intervention (OGTT vs. EX) x time (T0, T30, T60, T90, T120 minutes)] 
ANOVA with repeated measures was used to determine interaction and main effects.  
When significant interaction effects were found, one-way ANOVAs with Bonferroni 
corrected pair-wise comparisons were used to determine where specific between-group 
differences were located and repeated measures ANOVAs were conducted on each 
treatment to determine where specific within-group differences were located.  
Additionally, multiple linear regression models were used to determine the association 
between total OC and uOC, and other selected variables.  An alpha of p ≤ 0.05 was used 
to determine significance for all statistical tests, and all analyses were performed using 
Predictive Analytics SoftWare statistics 18 package (PASW; Chicago, IL).  
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Chapter IV: Results 
Descriptive Data 
Descriptive and anthropometric data for the study subjects are listed in Table 3.  
The average heart rate for the whole group during the exercise session is depicted in 
Figure 3. The heart rates achieved at the end of each of the four high-intensity intervals 
corresponded to 78±10%, 84±6%, 87±5% and 89±6% of maximal HR, respectively. 
The average heart rate during the 25 minute exercise session (minus the warm-up and 
cool-down periods) was 151±11 beats per minute (77±5% heart rate max). 
Table 3. Subject characteristics. 
 Mean  SD 
Age (y) 21.40 ± 1.68 
Height (cm) 180.77 ± 7.80 
Weight (kg) 95.61 ± 14.85 
Body mass index (kg/m
2
) 29.15 ± 3.30 
Waist circumference (cm) 92.10 ± 9.03 
HOMA-IR 3.48 ± 4.26 
VO2max (mL O2/kg/min) 34.90 ± 6.50 
Maximal heart rate (bpm) 194.87 ± 10.74 
Body fat (%) 32.23 ± 7.66 
Fat mass (kg) 30.17 ± 10.27 
Lean mass (kg) 61.65 ± 7.84 
Total bone mineral content (kg) 3.59 ± 0.50 
Total bone mineral density (g/cm
2
) 1.32 ± 0.10 
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Figure 3. Average heart rate response during the exercise bout. 
 
 
 
Glucose and Insulin Data 
As shown in figure 4, there were no significant differences in baseline blood 
glucose between the OGTT and EX trials (99±8 vs 97±8 mg/dL, respectively).  No 
significant interaction effects were found between groups over time.  There was not a 
significant group effect; however, a significant time effect was found for glucose 
(p<0.001).  Post-hoc analysis revealed that glucose at T30 was significantly greater than 
all other time points (p<0.05 for all) and T60 was significantly greater than T120 
(p=0.012).  Additionally, there were no differences between OGTT and EX for glucose 
AUC (14.97±3.77 vs 14.23±4.08 mg min/dL/1000, respectively; p=0.123). 
Glucose AUC following the OGTT was significantly associated with BMI 
(r=0.550, p=0.34), waist circumference (r=0.525, p=0.044), body fat % (r=0.632, 
p=0.011) and total fat mass (r=0.605, p=0.017).  Blood glucose at T0 following EX was 
significantly and negatively correlated with total (r=-0.631, p=0.012) and leg (r=-0.619, 
p=0.014) BMC. 
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Figure 4. Blood glucose at each time point (left panel) and area under the curve 
(right panel) for OGTT (open circles and bars) and EX (closed circles and bars). 
Individual delta glucose AUC response to EX relative to OGTT (bottom panel). 
Data are mean ± SD. * significantly different than time 0. 
 
 
There were no significant differences in baseline serum insulin between the 
OGTT and EX trials (14.22±17.48 vs 15.08±17.84 µU/mL, respectively).  Similar to 
glucose, no significant interaction effects were found between groups over time and no 
differences were present between groups.  A significant time effect was found for 
insulin (p<0.001).  As shown in Figure 5, insulin at T30 was significantly elevated 
compared to T0 (p<0.001) and T60 was significantly greater than T0 (p=0.003) and 
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T120 (p=0.002).  There wasn’t a significant difference between OGTT and EX for 
insulin AUC (13.62±11.78 VS 12.66±10.17 µU min/mL/1000, respectively; p=0.311).    
In addition, oral glucose insulin sensitivity was not significantly different between 
OGTT and EX (Figure 5; 369±73 vs 393±87 mL min/m
2
, respectively). 
As indicated in Table 4, baseline (T0) serum insulin and insulin AUC during 
OGTT were significantly associated with weight, BMI, waist circumference, body fat % 
and total fat mass.  Exercise mitigated the associations between T0 serum insulin and 
BMI, waist circumference and total fat mass.  Exercise also diminished the relationship 
between insulin AUC and BMI.  The lack of an association between insulin AUC and 
BMI following exercise appears to be due to decreased insulin AUC for subjects with 
higher BMIs.  Insulin AUC (both OGTT and EX) was also significantly negatively 
associated with VO2max (r=-0.588 and -0.645, respectively; p<0.05). 
Table 4. Correlation coefficients for insulin at T0 and insulin AUC for OGTT and 
EX.  Bold indicates significant association. 
 OGTT EX 
 T0 Insulin Insulin AUC T0 Insulin Insulin AUC 
Weight 0.620 0.293 0.146 0.170 
BMI 0.717 0.541 0.158 0.432 
Waist Circumference 0.751 0.638 0.473 0.535 
Body Fat % 0.602 0.623 0.630 0.628 
Fat Mass 0.729 0.597 0.507 0.534 
Lean Mass 0.184 -0.217 -0.361 -0.361 
Bone Mineral Density -0.018 -0.320 -0.526 -0.402 
Bone Mineral Content <0.001 -0.341 -0.240 -0.385 
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Figure 5. Serum insulin at each time point (left panel) and area under the curve 
(right panel) for OGTT (open circles and bars) and EX (closed circles and bars). 
Individual delta insulin AUC response to EX relative to OGTT (bottom panel). 
Data are mean ± SD. * significantly different than time 0. 
 
 
Exercise (393±87 mL min/m
2
) marginally improved OGIS compared to rest 
(369±73 mL min/m
2
), but this improvement did not reach statistical significance 
(p=0.06; Figure 6).  OGIS was significantly negatively associated with BMI (r=-0.623, 
p=0.013), waist circumference (r=-0.636, p=0.011), body fat percentage (r=-0.627, 
p=0.012) and fat mass (r=-0.632, p=0.011) during the OGTT visit.  Exercise eliminated 
all of these associations suggesting that those with greater adiposity had a greater 
improvement in insulin sensitivity following exercise. 
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Figure 6. Oral glucose insulin sensitivity for OGTT (open bar) and EX (closed 
bar). 
 
 
 
Osteocalcin Data 
As depicted in Figure 7, there were no significant differences in baseline serum 
cOC between the OGTT and EX trials (32.24±21.32 vs 26.86±15.68 ng/mL, 
respectively).  There were no significant interaction effects between groups over time, 
nor were there main effects of group or time.  There was also no significant difference 
between OGTT and EX for cOC AUC (3466±2238 vs.3345±1873 ng min/mL, 
respectively; p=0.470). 
As depicted in Figure 8, the difference in cOC AUC between the EX and OGTT 
trials was significantly negatively associated with lean mass and BMD (r=-0.600 and 
r=-0.548, respectively; p<0.05).  This difference in cOC AUC was significantly 
correlated with the difference in glucose AUC (r=0.540, p=0.038). 
 
Figure 7. Serum carboxylated osteocalcin at each time point (top left panel) and 
area under the curve (top right panel) for OGTT (open circles and bars) and EX 
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(closed circles and bars). Individual delta cOC AUC response to EX relative to 
OGTT (bottom panel). Data are mean ± SD 
 
 
Figure 8. Association of lean mass (A), bone mineral density (B) and delta glucose 
AUC (C) with delta cOC AUC response to EX relative to OGTT. 
 
As depicted in Figure 9, there were no significant differences in baseline serum 
uOC between the OGTT and EX trials (8.48±3.23 vs 9.03±3.68 ng/mL, respectively).  
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There were no significant interaction effects between groups over time, nor were there 
main group or time effects were.  There was also no significant difference between 
OGTT and EX for uOC AUC (932±385 vs. 989±422 ng min/mL, respectively; 
p=0.295). 
 
Figure 9.  Serum undercarboxylated osteocalcin at each time point (left panel) and 
area under the curve (right panel) for OGTT (open circles and bars) and EX 
(closed circles and bars). Individual delta uOC AUC response to EX relative to 
OGTT (bottom panel). Data are mean ± SD. 
  
 
There were no significant differences in baseline serum tOC between the OGTT 
and EX trials (40.72±20.88 vs 35.90±17.98 ng/mL, respectively).  There were no 
significant interaction effects for tOC between groups over time, nor were there main 
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group or time effects.  There was also no significant difference between OGTT and EX 
for tOC AUC (4399±2319 vs. 4334±2018 ng min/mL, respectively; p=0.727).  Data 
shown in Figure 10. 
 
Figure 10. Total serum osteocalcin at each time point (left panel) and area under 
the curve (right panel) for OGTT (open circles and bars) and EX (closed circles 
and bars). Individual delta tOC AUC response to EX relative to OGTT (bottom 
panel). Data are mean ± SD. 
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Chapter V: Discussion 
The main findings from this study are that cOC, uOC and tOC are not altered 
following glucose intake in overweight young men, either with rest or a single bout of 
aerobic interval exercise before the glucose drink.  Additionally, cOC, uOC or tOC 
were not significantly correlated with either baseline or postprandial concentrations of 
glucose and insulin, or components of body composition (i.e. fat mass, lean mass, bone 
mineral content, bone mineral density). 
One of the main findings of the current study is that serum cOC, uOC and tOC 
did not significantly change following glucose intake as was hypothesized and had been 
previously reported [73, 79].  In a 2012 study, Paldánius et al. [73] reported that a 
standard 75g oral glucose tolerance test resulted in a 32% and 34% decrease in OC and 
cOC, respectively, in normoglycemic young adults.  The results of the current study 
reveal only an 18% and 21% decrease in tOC and cOC, respectively.  Although that 
magnitude of change is similar to a more recent study by Paldánius et al [79] in the 
latter study the change in response to oral glucose reached statistical significance.  
While the 2012 Paldánius et al. study and the current study reported that subjects were 
normoglycemic, the current study’s subjects had a fasting glucose of 90-115 mg/dL, 
whereas Paldánius et al. had subjects with glucose concentrations of 68-99 mg/dL.  
Additionally, at the 120-minute time point, Paldánius et al. reported glucose 
concentrations of 52-166 mg/dL in their subjects whereas the current study subjects had 
glucose of 66-202 mg/dL.  Since baseline and 120-minute glucose concentrations 
during the current study were slightly elevated compared to Paldánius et al., this could 
account for the 13%-14% differences between the current study and those previously 
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reported.  Additionally, Paldánius et al. reported baseline sampling times between 0805 
and 1102.  Since OC has been shown to have a diurnal variation [27], the results 
reported by Paldáius et al. could have been influenced by the circadian rhythm.  In the 
current study all baseline samples were collected between 0850 and 0905; therefore it is 
unlikely that the naturally occurring circadian rhythm influenced our results.  However, 
the average percent change in OC in the current study is similar to that reported in 
previous studies [80, 81].  Additionally, a prior study suggested that  the effect of OC 
on glucose metabolism may be more evident over a long term observation compared to 
the acute regulation of a single carbohydrate meal [79].  As in the current study, 
Paldánius et al. [79] did not find significant associations between postprandial OC and 
glucose or insulin.  In summary, unlike previously published studies, glucose intake did 
not result in a significant decrease in cOC, uOC or tOC during the current study, which 
could be explained by the large inter-individual variation in these markers during the 
current study since the average percent changes were similar to those previously 
reported. 
The decrease in postprandial OC reported previously [73, 79] and the non-
significant trend for decline in the current study seem to contradict the insulin feedback 
loop reported by Karsenty and colleagues [33] as there is a robust transient increase in 
insulin following the OGTT.  However, the duration of insulin exposure needed to 
stimulate the release of uOC from bone is unknown, and it is also unclear whether the 
feedback loop observed in vitro is similar in humans [82, 83].  Future studies should 
examine the effects of long-term or repeated exposure to elevated insulin concentrations 
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on serum OC to determine whether duration, magnitude or frequency of insulin 
exposure may alter the insulin-OC feedback loop. 
Within the current study, T0 was within 15 minutes after cessation of the 
exercise bout, but no blood was taken prior to the exercise bout so the actual effect of 
exercise alone could not be reported.  However, since all participant were instructed to 
repeat their diet and exercise regimen for 3 days prior to each exercise visit and the 
baseline sampling at the same time of day on each visit, it can be cautiously interpreted 
that differences in selected outcome values at T0 on the OGTT visit versus EX visit is 
attributable to the exercise bout.  The results of the current study contrast those 
described by Levinger et al. [71] who reported increased uOC and tOC concentrations 
following an acute bout of aerobic exercise in middle-aged, obese men.  Levinger et al. 
utilized an exercise protocol consisting of a 45-minute cycling bout performed at a heart 
rate that corresponded to 70-75% VO2peak.  In response to that exercise session uOC 
was increased ~6% and tOC >10% at 120 minutes post-exercise compared the resting 
baseline values.  While uOC or tOC was not measured prior to the exercise bout in the 
current study, uOC was 6.5% greater and tOC was 12% less at T0 following exercise 
compared to the subjects T0 during the OGTT visit.  The differences in the reported 
findings are likely due to the large difference in age of the two subject pools and the 
large inter-individual variation in the current study.  The subjects in the Levinger et al. 
study were an average of 53 years old whereas participants in the current study were 21 
years old.  Previous research has reported that younger males have higher serum OC 
concentrations compared to middle-aged men [84, 85].  Since it has been previously 
reported that men with lower basal OC concentrations have an increased response to 
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exercise [74], the expected lower basal OC concentrations in the middle-aged men 
studied by Levinger et al. could explain the significant increases they reported.  
Additionally, while Levinger et al.  reported that their subjects had fasting glucose 
concentration of 123 mg/dL (6.8mmol/L), indicating that the participants had either 
impaired fasting glucose or diabetes (N = 6 of the 13 participants).  In the current study 
the average fasting glucose was 99 mg/dL; all subjects had either normal or mildly 
impaired fasting glucose.  Since T2D is associated with reduced circulating levels of 
OC [71, 86] it is possible that  people with insulin resistance, such as those in the 
Levinger et al. study, have larger magnitude of increase in OC in response to exercise.  
Future investigations should examine the response of serum OC to exercise in subjects 
with varying degrees of glycemia in order to determine possible influence of OC during 
and following exercise on glucose regulation. 
The lack of effect of the acute exercise bout to alter serum OC in this study is in 
agreement with previous reports [65, 66, 87, 88].  Tosun et al. [65] reported that serum 
OC was unchanged in sedentary young women following 30 minutes of brisk walking 
(60-85% HRmax) with or without a weighted (5kg) backpack.  Welsh et al. [66] also 
observed no change in serum OC following a single bout of brisk treadmill walking in 
healthy, young men.  Interestingly, Nishiyama et al. [62] reported that athletic and 
nonathletic males had differing responses in OC following aerobic exercise.  They 
revealed that OC response peaks 60 minutes following cessation of exercise in athletic 
men, but in nonathletic males the peak response in OC occurs immediately following 
exercise.  In our study, there was a large variation in postprandial OC response to 
exercise that could be related to the training history of the individuals.  While all 
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subjects in our study were sedentary just prior to and during the course of the study, it is 
likely that they have varying degrees of athletic backgrounds.  This difference in 
training could result in an alteration in the response of OC to the exercise bout and 
glucose load leading to the large postprandial variation.  It could be of interest in future 
studies to examine young adults with or without previous training history to examine if 
an athletic background may have long term effects on serum OC and the response of 
OC to exercise.  Additionally, it is possible that the effect of exercise on OC is transient. 
Ma moun et al. [64] reported that trained cyclists had an immediate increase in OC 
following 50 minutes of cycling at 15% above their ventilatory threshold, but this 
increase was abolished within 15 minutes following exercise.  The OGTT in the current 
study began 10-15 minutes following the cessation of exercise so it is possible that any 
change in OC occurred within the timeframe prior to the OGTT but following exercise.  
It is unclear if such a transient response could have an impact on subsequent 
postprandial glucose or insulin response.  
 There may be role for exercise volume or intensity as a regulating factor for OC 
response to physical activity.  It was reported that an exercise routine that requiring a 
negative energy balance of 1200-1500 kilocalories (~2 hours of exercise) resulted in a 
24% increase in OC of trained rowers [89].  The authors also reported that OC 
concentrations measured immediately following exercise were related to the distance 
covered during the exercise.  Therefore, it is possible that the exercise protocol used 
during the current study was not strenuous enough to elicit an increase in OC.  The 
subjects expended 241-498 kilocalories during the exercise protocol.  However, the 
treadmill activity in the current study was designed to be appropriate for overweight, 
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untrained young men who were unaccustomed to vigorous exercise and the exercise 
protocol was completed by all subjects, demonstrating feasibility and generalizability 
for young adults.  Levinger et al. [71] observed an increase in OC following an exercise 
bout that would have elicited a similar energy expenditure in the current study, albeit at 
a consistently lower intensity.  Still, it is possible that a greater change in OC may have 
occurred if a longer duration of exercise had been performed by the young men in the 
current study. 
While the results from current study did not reveal an acute change in OC 
following exercise, previous studies have shown that exercise training involving a 
similar style of exercise results in increased OC [67, 90].  Long-term aerobic exercise, 
even with the presence of weight-loss, results in increased OC [67, 90].  However, not 
all studies are in accordance with these results [91, 92].  The previous studies that have 
examined the effect of exercise training on OC in a younger population (<50 years old) 
have generally shown increases in OC; however, when an older population is studied, 
exercise training has been reported to decrease OC.  Nevertheless, there are no studies 
that have examined the effect of the exercise training on the association between OC 
and glucose metabolism in young people. 
Contrary to expectation, the single session of intermittent high-intensity aerobic 
exercise did not modify postprandial glucose or insulin response to a standard OGTT.  
Previous studies have reported that an acute bout of aerobic exercise can have 
immediate effects on postprandial glucose and insulin response in young adults [93].  
Short et al. [93] reported a 6% reduction in glucose AUC and a 20% decrease in insulin 
AUC 1-hour following a 45-minute moderate intensity exercise bout.  In the current 
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study, there was a 5% reduction in glucose AUC and a 6% reduction in insulin AUC, 
neither of which were significant.  Short et al. used a “mixed meal test” consisting of 
45%, 40% and 15% of energy from carbohydrate, fat and protein, respectively.  It is 
possible that the effect of exercise on glucose control following a meal differs from a 
glucose-only drink, but has not, to our knowledge, been examined.  Additionally, Short 
et al. utilized 3 different exercise modes, 15 minutes each of walking, stationary 
cycling, and video game boxing, during their 45-minute exercise bout which would 
activate a larger amount of muscle mass and could result in increased glucose uptake 
compared to the current study, which utilized only treadmill walking.  Insulin sensitivity 
following a single exercise session has been shown to increase in some [94-97] but not 
all [98-101] previous studies.  This discord in the previously published reports is likely 
due to the type of insulin sensitivity test (OGTT vs. hyperinsulinemic, euglycemic 
clamp), time between the exercise bout and glucose test (immediately following vs. 12-
48 hours following exercise) and the population studied (age, ethnicity, glycemic 
status).  To our knowledge, Short et al. [93] and the current study are the only studies to 
examine the effect of a single aerobic exercise session on postprandial glucose and 
insulin response immediately after an aerobic exercise bout.   
Although the exercise bout did not significantly decrease glucose or insulin 
AUC in the whole group, a comparison of individual responses showed that 11 and 8 
subjects had decreases in AUC for glucose and insulin, respectively.  The measure of 
OGIS, which incorporates changes in both glucose and insulin into a single outcome, 
revealed a stronger effect of exercise compared to the AUC values.  Exercise increased 
OGIS by 6.5% in the current study and although this improvement only produced a 
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trend (p=0.06), this measure is likely a more accurate representation of the effect of 
exercise on insulin sensitivity as it has been shown to be in agreement with the more 
sensitive hyperinsulinemic, euglycemic clamp method [78].  Although in the acute 
timeframe utilized in this study insulin sensitivity was not significantly improved, it 
could be hypothesized that repeated exposure to this type of exercise stimulus could 
lead to long-term benefits in glucose metabolism.  As previously stated, short-term 
effects of exercise on insulin sensitivity are equivocal; however exercise training has 
been proven to improve insulin sensitivity so it is likely that this study produced 
expected results for the timeframe it was performed. 
In the current study baseline (T0) serum cOC, uOC and tOC concentrations 
were not associated with fat mass, lean mass, and bone mineral content or density as 
hypothesized.  Several studies have shown negative associations between fat mass and 
OC across a wide age range [11, 12, 51-53, 55, 102].  These studies have used much 
larger sample sizes than the current study so in comparison the current study is vastly 
underpowered.  However, not all previous studies have reported an association between 
OC and adiposity [103].  Given the relatively small sample size and the large variability 
in OC for the current study, it is difficult to assess the association between OC and fat 
mass, lean mass, and bone mineral content or density. 
   Limitations of the current study include a relatively small sample size and low 
exercise volume compared to some other studies.  Given the large inter-individual 
response in glucose, insulin and OC to both glucose ingestion and exercise during the 
current study, the sample size utilized may be too small to reveal significant changes in 
any of the listed variables.  However, a priori sample size calculations were done using 
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previously published studies on OC response to glucose ingestion [73] and aerobic 
exercise [71] which established that a sample size of 15 was sufficient for the current 
study.  However, there was greater heterogeneity in several outcomes than predicted.  
This may be attributable to the inclusion of subjects with a relatively wide range in 
fitness and adiposity, both of which may modify circulating OC at rest and in response 
to exercise.  Those subject characteristics may need to be more tightly controlled or 
used as covariates in future investigations.  Another consideration is the exercise 
session.  The exercise bout resulted in an average estimated energy expenditure of ~330 
kilocalories, this is less than the energy expenditure reported in previous studies using 
young men who were trained athletes [89].  At present it is unclear if OC would 
increase following exercise performed by young overweight men if the exercise volume 
was increased, or if several sessions of exercise are needed before changes in OC are 
elicited.  Nonetheless, the exercise bout in the current study was designed to be 
generalizable to the general population of apparently health, yet untrained young adults.  
Additionally, the energy expenditure is likely similar to that of a recently published 
study [71] that did find significant differences in OC following an acute bout of aerobic 
exercise in an older population. 
 Future investigations could examine both acute and long-term exercise effects 
on OC (including total, carboxylated and undercarboxylated) and glucose tolerance in a 
range of glucose tolerant people.  Since it has been previously reported that people with 
decreased glucose tolerance have lower OC and that people lower basal OC 
concentrations will have an increased response to exercise, it could be hypothesized that 
a study covering a range of glucose tolerance may result in differential results between 
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these groups.  Additionally, both aerobic [90] and resistance training [47] have been 
shown to increase OC.  Resistance training is emerging as an effective exercise mode to 
improve glucose metabolism [104-106].  Thus, future investigations should determine if 
aerobic training, resistance training, or a combination of both differentially alter serum 
OC, blood glucose and insulin.  It is plausible to predict that resistance training would 
stimulate more bone formation and subsequent release of OC into circulation.  Such a 
study would aid in delineating the influence of OC on glucose metabolism. 
In summary, ingestion of glucose with or without a prior aerobic exercise bout 
did not result in changes in postprandial OC concentration. OC was not related to 
postprandial changes in blood glucose, insulin or with any body composition measure.  
While the exercise bout did not alter postprandial OC, there was also minimal effect on 
postprandial glucose or insulin; therefore any conclusions that exercise does not 
influence the relationship of postprandial OC and glucose or insulin should be 
considered in that context and with restraint.  If glucose and insulin were significantly 
reduced following exercise it is possible that they may also have been an accompanying 
change in OC.  Regardless, these data are the first to examine the postprandial response 
of serum OC within the 2-hour timeframe of a standard OGTT, and with careful control 
for potential diurnal variations.  Additionally, this study is the first to establish that an 
acute exercise bout just prior to consumption of glucose does not alter postprandial OC 
in overweight young men.  This novel study lends insight into the transient postprandial 
associations between blood glucose, insulin and OC concentration and the effect that a 
single bout of exercise has on those associations.  These results could act as a 
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foundation for future research examining the long-term effects of exercise on the 
regulation of glucose metabolism by the osseous tissue. 
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